Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Magn Reson Med. 2016 Feb 26;77(2):814–825. doi: 10.1002/mrm.26167

Figure 3.

Figure 3

Diagnostic CT (a), pre- (b) and post-ferumoxytol (c) T2-weighted MRI scans from a representative patient with several large, partially necrotic liver metastases from colorectal cancer. ΔR2 and ΔR2* maps (d, e) and Q and ADC maps (f, g) are also shown. The target lesion for ROI measurements is highlighted in (d).